Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mitkare Sachin, Dolare Sachin & Sakarkar Dinesh. (2017) Voyage of theranostic liposomes for imaging and therapy. Journal of Cosmetic and Laser Therapy 19:4, pages 245-249.
Read now
Read now
L. Livi, I. Meattini, V. Scotti, C. De Luca Cardillo, A. Galardi, C. Iermano, L. Sanchez, J. Nori, M. Mangoni, C. Franzese, L. Orzalesi, S. Bertocci, B. Agresti, T. Masoni, S. Bianchi, L. Cataliotti & G. Biti. (2011) Pegylated Liposomal Doxorubicin (Caelyx®) and Oral Vinorelbine in First-Line Metastatic Breast Cancer Patients Previously Treated with Anthracyclines. Journal of Chemotherapy 23:3, pages 158-162.
Read now
Read now
Articles from other publishers (16)
Stanislav Filip, Ondřej Kubeček, Jiří Špaček, Miriam Lánská & Milan Bláha. (2020) Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. Pharmaceutics 12:10, pages 940.
Crossref
Crossref
Xuwu Zhang, Yanping Liu, Liyao Luo, Lei Li, Shanshan Xing, Tian Yin, Kexin Bian, Ruiyan Zhu & Dawei Gao. (2019) A chemo-photothermal synergetic antitumor drug delivery system: Gold nanoshell coated wedelolactone liposome. Materials Science and Engineering: C 101, pages 505-512.
Crossref
Crossref
Neus Lozano, Zahraa S. Al-Ahmady, Nicolas S. Beziere, Vasilis Ntziachristos & Kostas Kostarelos. (2015) Monoclonal antibody-targeted PEGylated liposome-ICG encapsulating doxorubicin as a potential theranostic agent. International Journal of Pharmaceutics 482:1-2, pages 2-10.
Crossref
Crossref
Nicolas Beziere, Neus Lozano, Antonio Nunes, Juan Salichs, Daniel Queiros, Kostas Kostarelos & Vasilis Ntziachristos. (2015) Dynamic imaging of PEGylated indocyanine green (ICG) liposomes within the tumor microenvironment using multi-spectral optoacoustic tomography (MSOT). Biomaterials 37, pages 415-424.
Crossref
Crossref
Yung Hyun Choi, Dong Yeok Shin & Wun-Jae Kim. (2014) Inhibition of Migration and Invasion of LNCap Human Prostate Carcinoma Cells by Doxorubicin through Inhibition of Matrix Metalloproteinase Activity and Tightening of Tight Junctions. Journal of Life Science 24:6, pages 700-706.
Crossref
Crossref
Milena Gusella, Antonio Bononi, Yasmina Modena, Laura Bertolaso, Paola Franceschetti, Daniela Menon, Elisa Pezzolo, Carmen Barile, Giorgio Crepaldi, Caterina Bolzonella, Alessandro Inno, Roberto Padrini & Felice Pasini. (2014) Age affects pegylated liposomal doxorubicin elimination and tolerability in patients over 70?years old. Cancer Chemotherapy and Pharmacology 73:3, pages 517-524.
Crossref
Crossref
James B DelehantyJoyce C Breger, Kelly Boeneman Gemmill, Michael H Stewart & Igor L Medintz. (2013) Controlling the actuation of therapeutic nanomaterials: enabling nanoparticle-mediated drug delivery. Therapeutic Delivery 4:11, pages 1411-1429.
Crossref
Crossref
Umberto Basso, Anna Roma, Antonella Brunello, Cristina Falci, Pasquale Fiduccia, Alberto Banzato, Antonio Bononi, Milena Gusella, Lampros Vamvakas, Vittorina Zagonel & Silvio Monfardini. (2013) Bi-weekly liposomal doxorubicin for advanced breast cancer in elderly women (≥70years). Journal of Geriatric Oncology 4:4, pages 340-345.
Crossref
Crossref
C. Falandry, E. Brain, M. Bonnefoy, F. Mefti, N. Jovenin, O. Rigal, O. Guillem, C. El Kouri, L. Uwer, S. Abadie-Lacourtoisie, J. Cretin, J.P. Jacquin, D. Paraiso & G. Freyer. (2013) Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: Final results of the DOGMES multicentre GINECO trial. European Journal of Cancer 49:13, pages 2806-2814.
Crossref
Crossref
Dimitrios Bitounis, Raphaelle Fanciullino, Athanassios Iliadis & Joseph Ciccolini. (2012) Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept. ISRN Pharmaceutics 2012, pages 1-11.
Crossref
Crossref
Wafa’ T. Al-Jamal & Kostas Kostarelos. (2011) Liposomes: From a Clinically Established Drug Delivery System to a Nanoparticle Platform for Theranostic Nanomedicine. Accounts of Chemical Research 44:10, pages 1094-1104.
Crossref
Crossref
Golam Kibria, Hiroto Hatakeyama & Hideyoshi Harashima. (2011) A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system. International Journal of Pharmaceutics 412:1-2, pages 106-114.
Crossref
Crossref
Jens Huober, Werner Fett, Arnd Nusch, Michael Neise, Marcus Schmidt, Arthur Wischnik, Steffen Gerhardt, Thomas Goehler, Hans-Joachim Lück & Andreas Rost. (2010) A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer. BMC Cancer 10:1.
Crossref
Crossref
Claudia Andreetta, Alessandro M. Minisini, Manuela Miscoria & Fabio Puglisi. (2010) First-line chemotherapy with or without biologic agents for metastatic breast cancer. Critical Reviews in Oncology/Hematology 76:2, pages 99-111.
Crossref
Crossref
Tong-Hsien Chow, Yi-Yu Lin, Jeng-Jong Hwang, Hsin-Ell Wang, Yun-Long Tseng, Victor Fei Pang, Ren-Shyan Liu, Wuu-Jyh Lin, Chung-Shi Yang & Gann Ting. (2009)
Therapeutic Efficacy Evaluation of
111
In-Labeled PEGylated Liposomal Vinorelbine in Murine Colon Carcinoma with Multimodalities of Molecular Imaging
. Journal of Nuclear Medicine 50:12, pages 2073-2081.
Crossref
Crossref
Donato Cosco, Alessandra Bulotta, Monica Ventura, Christian Celia, Teresa Calimeri, Gino Perri, Donatella Paolino, Nicola Costa, Paola Neri, Pierosandro Tagliaferri, Pierfrancesco Tassone & Massimo Fresta. (2009) In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer. Cancer Chemotherapy and Pharmacology 64:5, pages 1009-1020.
Crossref
Crossref